【レポートの概要（一部）】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition and Scope
3.2. Parent Market Overview
3.3. Key Forces Shaping Narcolepsy Drugs Market
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low bargaining power of buyers
3.3.3. Low threat of new entrants
3.3.4. Moderate threat of substitutes
3.3.5. Moderate intensity of rivalry
3.4. Pricing Analysis
3.4.1. Pricing Analysis, By Region, 2018 & 2025
3.5. Market Evolution
3.6. Value Chain Analysis
3.7. Impact of government regulations on global narcolepsy drugs market
3.8. Patent Analysis
3.8.1. By Region
3.8.2. By Applicant
3.9. Market Dynamics
3.9.1. Drivers
3.9.1.1. Increase in global prevalence of narcolepsy
3.9.1.2. Narcolepsy awareness programs and services
3.9.1.3. Presence of reimbursement policies regarding narcolepsy
3.9.2. Restraints
3.9.2.1. Adverse effects and risks related to narcolepsy drugs
3.9.2.2. Delayed diagnosis or misdiagnosis
3.9.3. Opportunity
3.9.3.1. Untapped markets in the developing countries
CHAPTER 4: NARCOLEPSY DRUGS MARKET, BY DISEASE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Daytime Extreme Sleepiness
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Cataplexia
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Other Disease Type
4.4.1. Key market trends and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: NARCOLEPSY DRUGS MARKET, BY THERAPEUTIC TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Central Nervous System Stimulants
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Tricyclic Antidepressants
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Sodium Oxybate
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Selective Serotonin Reuptake Inhibitor
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Other Therapeutic Type
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
CHAPTER 6: NARCOLEPSY DRUGS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America market size and forecast, by disease type
6.2.3. North America market size and forecast, by therapeutic type
6.2.4. North America market size and forecast, by country
6.2.4.1. U.S. market size and forecast, by disease type
6.2.4.2. U.S. market size and forecast, by therapeutic type
6.2.4.3. Canada market size and forecast, by disease type
6.2.4.4. Canada market size and forecast, by therapeutic type
6.2.4.5. Mexico market size and forecast, by disease type
6.2.4.6. Mexico market size and forecast, by therapeutic type
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe market size and forecast, by disease type
6.3.3. Europe market size and forecast, by therapeutic type
6.3.4. Europe market size and forecast, by country
6.3.4.1. Germany market size and forecast, by disease type
6.3.4.2. Germany market size and forecast, by therapeutic type
6.3.4.3. France market size and forecast, by disease type
6.3.4.4. France market size and forecast, by therapeutic type
6.3.4.5. UK market size and forecast, by disease type
6.3.4.6. UK market size and forecast, by therapeutic type
6.3.4.7. Italy market size and forecast, by disease type
6.3.4.8. Italy market size and forecast, by therapeutic type
6.3.4.9. Spain market size and forecast, by disease type
6.3.4.10. Spain market size and forecast, by therapeutic type
6.3.4.11. Rest of Europe market size and forecast, by disease type
6.3.4.12. Rest of Europe market size and forecast, by therapeutic type
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific market size and forecast, by disease type
6.4.3. Asia-Pacific market size and forecast, by therapeutic type
6.4.4. Asia-Pacific market size and forecast, by country
6.4.4.1. Japan market size and forecast, by disease type
6.4.4.2. Japan market size and forecast, by therapeutic type
6.4.4.3. China market size and forecast, by disease type
6.4.4.4. China market size and forecast, by therapeutic type
6.4.4.5. Australia market size and forecast, by disease type
6.4.4.6. Australia market size and forecast, by therapeutic type
6.4.4.7. India market size and forecast, by disease type
6.4.4.8. India market size and forecast, by therapeutic type
6.4.4.9. South Korea market size and forecast, by disease type
6.4.4.10. South Korea market size and forecast, by therapeutic type
6.4.4.11. Rest of Asia-Pacific market size and forecast, by disease type
6.4.4.12. Rest of Asia-Pacific market size and forecast, by therapeutic type
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA market size and forecast, by disease type
6.5.3. LAMEA market size and forecast, by therapeutic type
6.5.4. LAMEA market size and forecast, by country
6.5.4.1. Brazil market size and forecast, by disease type
6.5.4.2. Brazil market size and forecast, by therapeutic type
6.5.4.3. Saudi market size and forecast, by disease type
6.5.4.4. Saudi market size and forecast, by therapeutic type
6.5.4.5. South Africa market size and forecast, by disease type
6.5.4.6. South Africa market size and forecast, by therapeutic type
6.5.4.7. Rest of LAMEA market size and forecast, by disease type
6.5.4.8. Rest of LAMEA market size and forecast, by therapeutic type
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Market Share Analysis of Top Players, 2018 (%)
7.3. Product Mapping of Top Players
7.4. Competitive Heatmap
CHAPTER 8: COMPANY PROFILES
8.1. ARENA PHARMACEUTICAL, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.2. BIOPROJET PHARMA SARL
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.3. JAZZ PHARMACEUTICAL PLC
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Operating segments
8.3.5. Business Performance
8.3.6. Key strategic moves and developments
8.4. LIGAND PHARMACEUTICALS INCORPORATED
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.5. NOVARTIS INTERNATIONAL AG
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.6. SHINOGI INC.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.7. TAKEDA PHARMACEUTICAL COMPANY
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
【レポート販売概要】
■ タイトル：ナルコレプシー治療薬の世界市場：疾患種類別、治療種類別■ 英文：Narcolepsy Drugs Market by Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others) and Therapeutics Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日：2019年7月
■ 調査会社：Allied Market Research
■ 商品コード：AMR9NV071
■ 調査対象地域：グローバル
- 超音波装置の世界市場予測（～2023年）“The ultrasound market is projected to grow at a CAGR of 5.9%”The global ultrasound market is projected to reach USD 8.4 billion by 2023 from USD 6.3 billion in 2018, at a CAGR of 5.9%. Factors such as the increasing prevalence of target diseases; rising patient preference for minimally invasive procedures; technological advancements; increasing number of diagnostic centers & hospitals; and growin …
- バイオベース・ポリウレタンの世界市場2016-2020About Bio-based Polyurethane Adipic acid, a petroleum-based compound, and few other di-acids are the commonly used conventional raw materials for manufacturing polyurethanes. However, natural oil polyols or bio-polyols derived from vegetable oils can also be used for manufacturing polyurethanes. These products are called bio-based polyurethanes. The most common sources of natural oil polyols inclu …
- 金属除去液の世界市場2016-2020About Removal Fluids Removal fluids are categorized as lubricant or coolants fabricated particularly for metalworking processes, including stamping and machining. There are different sub-segments of removal fluids include oils, oil-water emulsions, air, aerosols (mists), pastes, gels, and gases. Removal fluids may be fabricated with the help of petroleum distillates, plant oils, animal fats, air a …
- Panhandle Oil and Gas Inc.：石油・ガスバリューチェーン分析レポート2013Panhandle Oil and Gas Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Panhandle Oil and Gas Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Panhandle Oil and Gas Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chai …
- 自動車用バルブの世界市場2018-2022About Automotive Valves Automotive valves are used for controlling the flow of air-fuel mixture and other fluids in vehicles. Engine valves play a significant role in the automotive valves market. Technavio’s analysts forecast the global automotive valves market to grow at a CAGR of 5.41% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth pros …
- モバイルルーターの世界市場2015-2019About Mobile Hotspot Router A mobile hotspot is a very compact wireless router that enables end-users to avail high-speed Internet services without any wires, because devices are connected via 3G or 4G mobile connections. It provides connectivity within a range of 30-33 feet and allows end-users to connect multiple Wi-Fi-enabled devices to a single router, thereby helping reduce the overall cost o …
- FPS（浮体式海洋石油・ガス生産設備）の世界市場：FPSO、Semi-Submersible（セミサブ）、TLP（緊張係留式プラットフォーム）、Spar（スパー）About FPS FPS is an offshore production facility that is used for the production of hydrocarbons, the separation of oil, water, and gas, and the distribution of the yields to storage or transportation facilities. FPS is an essential part in the offshore oil and gas developments. It is used for drilling and exploration activities in offshore oil and gas production at all water depths. The main type …
- 頭頸部癌：世界の臨床試験レビュー（2014年上半期）Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Head And Neck Carcinoma Global Clinical Trials Review, H1, 2014" provides data on the Head And Neck Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Head And Neck Carcinoma. It includes an overview of the trial numbers …
- バイオバンクの世界市場2015-2019About Biobank Biobank is a biorepository for the preservation and collection of biological material used for diagnosis, biodiversity studies, and research. Depending on the aims of research, different biobanks store different kinds of samples such as tissues, blood, serum, DNA, and RNA. The human biobanks work by systematic collection of biological samples from patients and other members of the pu …
- データセンターネットワークインフラの世界市場2016-2020：イーサネットスイッチ、ルータ、ストレージネットワーキングAbout Data Center Network Infrastructure Data centers are used to house an enterprise IT infrastructure. In data centers, networking is the process involved for interconnecting physical and network-based devices. It enables communication between the server and storage infrastructure for the transfer of data between each other, in an external network, or across the internet. Technavio’s analysts fo …
- エストラジオールの市場別医療検査数および販売予測This new report from Venture Planning Group provides analysis of Estradiol testing, including clinical significance, current and emerging diagnostic procedures, as well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing - Hospitals - Commercial/Private Laboratories P …
- レビー小体型認知症治療のグローバル臨床試験動向（2014年H1）Lewy body Dementia Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Lewy body Dementia Global Clinical Trials Review, H1, 2014" provides data on the Lewy body Dementia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Lewy body Dementia. It includes an overview of the trial numbers and their recruitme …
- カジノゲーム装置の世界市場2017-2021：カジノテーブル、スロットマシーン、ゲームチップ、ビデオポーカー機械About Casino Gaming Equipment The global casino gaming equipment market is expected to grow at a CAGR of 15.25% during the forecast period. The easing of government regulations related to casino markets is one of the major factors contributing to the growing demand for casino gaming equipment. Many countries, such as Japan, are aiming at legalizing casino gaming because of the growing popularity o …
- 世界のカーエレクトロニクス市場（2012-2016）TechNavio's analysts forecast the Global Automotive Electronics market to grow at a CAGR of 3.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for entertainment devices. The market has also been witnessing a growth through integration of electronics in vehicles. However, decreased investment in automotive electronic devices du …
- 無人搬送車（AGV）の世界市場予測（～2022年）：ユニットロード運送車、牽引車、フォークリフトトラック、バレット輸送用トラック、組立ライン用車両The overall automated guided vehicle market is expected to reach USD 2.68 Billion by 2022, at a CAGR of 9.34% between 2017 and 2022. The growth of this market is propelled by the advancements in automation, emphasis on workplace safety and higher productivity, and increasing government initiatives in the process and manufacturing industries to track their material handling processes. The growth in …
